Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Seres Therapeutics (MCRB) Inventory (2023 - 2024)

Seres Therapeutics' Inventory history spans 2 years, with the latest figure at $53.0 million for Q2 2024.

  • For Q2 2024, Inventory rose 892.45% year-over-year to $53.0 million; the TTM value through Jun 2024 reached $53.0 million, up 892.45%, while the annual FY2023 figure was $29.6 million, N/A changed from the prior year.
  • Inventory for Q2 2024 was $53.0 million at Seres Therapeutics, up from $42.0 million in the prior quarter.
  • Across five years, Inventory topped out at $53.0 million in Q2 2024 and bottomed at $5.3 million in Q2 2023.